W ASHINGTON , DC - New therapies and treatments for diseases are compromised by a decline money, time, and training for clinical research, scientists said today at a joint meeting convened by the Institute of Medicine (IOM). Gaps in Clinical Research "will compromise our ability to bring innovation to health care at the bedside," warned Kenneth Shine, IOM President.
Most clinical research is performed in hospitals managed by medical schools. But the rise of managed care, such as health maintenance organizations (HMO), requires training and research hospitals to cut costs and competition. This "irrevocable rapid momentum to control costs ... is rapidly squeezing the time and money of clinical research, "George Lundberg, editor of the Journal of the American Medical Association ( JAMA ), at a press conference.
As evidence of this trend, Lundberg said a report JAMA published today that details how the cost reduction takes a toll on clinical research. a study of 50 university hospitals by Eric Campbell of Massachusetts General Hospital and colleagues, clinical researchers based at hospitals in more competitive markets (defined in part by numerous, large HMO) published on average, 15% fewer articles in peer-reviewed journals that had peers in less competitive markets. Campbell also found that faculty members in competitive hospitals reported more patient care duties and stress department that made them less competitive their colleagues.
To reverse the decline today called Shine a 1% tax on health care premiums and self-insurance plans to support clinical research. Gradually over several years, service estimates the tax could raise up to $ 5 billion per year that could be allocated in the form of peer-reviewed grants.
0 Komentar